♢ At the end of a title indicates that the FDA has not cleared prescription drugs, approved medical devices and/or biologics for the use described in this presentation. The prescription drugs, approved medical devices and/or biologics are being discussed for an off-label use.

Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Name
      Event Title
        Event Type
          Category-Classification
            Event Day

              456 C. difficile Infection Prior to Total Knee Arthroplasty Independently Increases the Risk of Prosthetic Joint Infection

              Author:Jens Verhey, BS  Sayi Boddu, BA  David Deckey, MD  Jack Haglin, MD,MS  Mark Spangehl, MD,FAAOS  Henry Clarke, MD,FAAOS  Joshua Bingham, MD, FAAOS  

              Event Title:(449-460) VIPER: Adult Reconstruction Knee V Papers  

              Event Type:Paper Presentations  

              Category-Classification:Adult Reconstruction Knee  

              Event Day:Thursday, March 13  

              536 Double DAIR for Acute-PJI: Positive Culture at Second Stage Increases the Risk of Subsequent Failure

              Author:Saad Tarabichi, MD  David Deckey, MD  Jens Verhey, MD  Carly Horne, BS  Zachary Christopher, MD  Henry Clarke, MD,FAAOS  Joshua Bingham, MD, FAAOS  Mark Spangehl, MD,FAAOS  

              Event Title:(533-540) VIPER: Adult Reconstruction Knee VII Papers  

              Event Type:Paper Presentations  

              Category-Classification:Adult Reconstruction Knee  

              Event Day:Thursday, March 13  

              e012 Double DAIR Technique for Chronic Periprosthetic Joint Infection: A Reasonable Salvage Option?

              Author:Saad Tarabichi, MD  Jaymeson Arthur, MD  Jose Iturregui, MD  David Deckey, MD  Jack Haglin, MD,MS  Roman Austin, BS  Henry Clarke, MD,FAAOS  Joshua Bingham, MD, FAAOS  Mark Spangehl, MD,FAAOS  

              Event Title:e001-e150 Adult Reconstruction Hip ePosters  

              Event Type:ePosters  

              Category-Classification:Adult Reconstruction Hip  

              Event Day:Monday, March 10  

              e155 WHICH MEDICATIONS ARE EFFECTIVE IN REDUCING RISK OF ARTHROFIBROSIS AFTER TOTAL KNEE ARTHROPLASTY?

              Author:Jens Verhey, BS  Rigel Hall, BS  David Deckey, MD  Ryan Lebens, BS  Joshua Bingham, MD, FAAOS  Henry Clarke, MD,FAAOS  Mark Spangehl, MD,FAAOS  

              Event Title:e151-e300 Adult Reconstruction Knee ePosters  

              Event Type:ePosters  

              Category-Classification:Adult Reconstruction Knee  

              Event Day:Monday, March 10  

              e162 Early Manipulation of a Stiff Total Knee Arthroplasty Increases Risk of Re-Manipulation

              Author:Jens Verhey, BS  Benjamin Paul, BS  Paul Van Schuyver, MD  Mark Spangehl, MD,FAAOS  Henry Clarke, MD,FAAOS  Joshua Bingham, MD, FAAOS  

              Event Title:e151-e300 Adult Reconstruction Knee ePosters  

              Event Type:ePosters  

              Category-Classification:Adult Reconstruction Knee  

              Event Day:Monday, March 10